Plante Moran Financial Advisors’s Regenxbio RGNX Stock Holding History

Plante Moran Financial Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,000	Closed	-$164K	–	815
2019 Q4	$164K	Buy	4,000 +3,500	+700%	+$138K	0.06%	181
2019 Q3	$18K	Buy	+500	New	+$20.3K	0.01%	519

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Plante Moran Financial Advisors's RGNX Position: Q1 2020 in Review

Plante Moran Financial Advisors sold out of Regenxbio (RGNX) in Q1 2020, closing a stake of 4,000 shares — an estimated $164K sold.

Plante Moran Financial Advisors first reported a position in RGNX in Q3 2019 and held it in 2 quarters. The position peaked at $164K in Q4 2019. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

Plante Moran Financial Advisors reported no remaining Regenxbio position as of Q1 2020 after selling out during the quarter.
Plante Moran Financial Advisors sold 4,000 Regenxbio shares in Q1 2020, an estimated $164K.
Plante Moran Financial Advisors first reported a position in Regenxbio in Q3 2019 and held it in 2 quarters.
Plante Moran Financial Advisors's Regenxbio position peaked at $164K in Q4 2019.
170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2020, filed 7 May 2020.